Difference between revisions of "LncRNAWiki:Featured"
Line 825: | Line 825: | ||
|_ | |_ | ||
|- | |- | ||
− | |||
|_ | |_ | ||
|[[DEC1]] | |[[DEC1]] | ||
Line 833: | Line 832: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[RN7SK]] | |[[RN7SK]] | ||
Line 840: | Line 840: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[RN7SL1]] | |[[RN7SL1]] | ||
Line 847: | Line 848: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[MYOPARR]] | |[[MYOPARR]] | ||
Line 854: | Line 856: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[PCED1B-AS1]] | |[[PCED1B-AS1]] | ||
Line 861: | Line 864: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[UMLILO]] | |[[UMLILO]] | ||
Line 868: | Line 872: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[LINC02631]] | |[[LINC02631]] | ||
Line 875: | Line 880: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[BMNCR]] | |[[BMNCR]] | ||
Line 882: | Line 888: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[ZEBTR]] | |[[ZEBTR]] | ||
Line 889: | Line 896: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[SNHG31]] | |[[SNHG31]] | ||
Line 896: | Line 904: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[ILF3-DT]] | |[[ILF3-DT]] | ||
Line 903: | Line 912: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[LINC00574]] | |[[LINC00574]] | ||
Line 910: | Line 920: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[CEBPA-DT]] | |[[CEBPA-DT]] | ||
Line 917: | Line 928: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[BABAM2-AS1]] | |[[BABAM2-AS1]] | ||
Line 924: | Line 936: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[]] | |[[]] | ||
Line 931: | Line 944: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[SNHG30]] | |[[SNHG30]] | ||
Line 938: | Line 952: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[RCC2-AS1]] | |[[RCC2-AS1]] | ||
Line 945: | Line 960: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[NIPBL-DT]] | |[[NIPBL-DT]] | ||
Line 952: | Line 968: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[PRDM16-DT]] | |[[PRDM16-DT]] | ||
Line 959: | Line 976: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[BCL6-AS1]] | |[[BCL6-AS1]] | ||
Line 966: | Line 984: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[C1orf220]] | |[[C1orf220]] | ||
Line 973: | Line 992: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[MIR122HG]] | |[[MIR122HG]] | ||
Line 980: | Line 1,000: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[RB1-DT]] | |[[RB1-DT]] | ||
Line 987: | Line 1,008: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[PANTR1]] | |[[PANTR1]] | ||
Line 994: | Line 1,016: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[C11orf72]] | |[[C11orf72]] | ||
Line 1,001: | Line 1,024: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[CT66]] | |[[CT66]] | ||
Line 1,008: | Line 1,032: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[CAPN10-DT]] | |[[CAPN10-DT]] | ||
Line 1,015: | Line 1,040: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[MIR1915HG]] | |[[MIR1915HG]] | ||
Line 1,022: | Line 1,048: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[CT75]] | |[[CT75]] | ||
Line 1,029: | Line 1,056: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[]] | |[[]] | ||
Line 1,036: | Line 1,064: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[MIR9-3HG]] | |[[MIR9-3HG]] | ||
Line 1,043: | Line 1,072: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[RN7SL2]] | |[[RN7SL2]] | ||
Line 1,050: | Line 1,080: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[RN7SL3]] | |[[RN7SL3]] | ||
Line 1,057: | Line 1,088: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[CT70]] | |[[CT70]] | ||
Line 1,064: | Line 1,096: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[CT69]] | |[[CT69]] | ||
Line 1,071: | Line 1,104: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[FLVCR1-DT]] | |[[FLVCR1-DT]] | ||
Line 1,078: | Line 1,112: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[C10orf91]] | |[[C10orf91]] | ||
Line 1,085: | Line 1,120: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[CEP83-DT]] | |[[CEP83-DT]] | ||
Line 1,092: | Line 1,128: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[CSTF3-DT]] | |[[CSTF3-DT]] | ||
Line 1,099: | Line 1,136: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[CTBP1-DT]] | |[[CTBP1-DT]] | ||
Line 1,106: | Line 1,144: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[FAM201B]] | |[[FAM201B]] | ||
Line 1,113: | Line 1,152: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[MAFG-DT]] | |[[MAFG-DT]] | ||
Line 1,120: | Line 1,160: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[RPP38-DT]] | |[[RPP38-DT]] | ||
Line 1,127: | Line 1,168: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[CDRT3]] | |[[CDRT3]] | ||
Line 1,134: | Line 1,176: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- | ||
|_ | |_ | ||
|[[DLEU2L]] | |[[DLEU2L]] | ||
Line 1,141: | Line 1,184: | ||
|_ | |_ | ||
|_ | |_ | ||
+ | |- |
Revision as of 06:29, 29 August 2019
LncBook ID | Symbol | Synonyms | Functional Mechanism | Biological Process | Disease | Mesh Ontology |
---|---|---|---|---|---|---|
HSALNT0267755 | LINC02597 | Transcriptional regulation | _ | Pathogenic process | Postmenopausal osteoporosis (PMOP) | Musculoskeletal Diseases |
HSALNT0178412 | UVRAG-DT | Transcriptional regulation | _ | Pathogenic process | Postmenopausal osteoporosis (PMOP) | Musculoskeletal Diseases |
HSALNT0185540 | LINC02598 | _ | _ | Pathogenic process | Lung squamous cell carcinoma (LUSC) | Neoplasms; Respiratory Tract Diseases |
HSALNT0278274 | SREBF2-AS1 | _ | _ | Pathogenic process | Lung squamous cell carcinoma (LUSC) | Neoplasms; Respiratory Tract Diseases |
HSALNT0021177 | LINC02602 | _ | _ | Pathogenic process | Non-small cell lung cancer (NSCLC) | Neoplasms; Respiratory Tract Diseases |
HSALNT0021052 | MIR205HG | CeRNA | _ | Pathogenic process | Head & neck squamous cell carcinoma (HNSCC) | Neoplasms |
HSALNT0107588 | ZNF451-AS1 | Transcriptional regulation | _ | Pathogenic process | Pancreatic ductal adenocarcinoma (PDAC) | Neoplasms |
HSALNT0189537 | SCAT2 | _ | _ | Pathogenic process | Kidney clear cell carcinoma (KIRC) | Neoplasm |
HSALNT0107867 | SCAT8 | _ | _ | Pathogenic process | Kidney clear cell carcinoma (KIRC) | Neoplasm |
HSALNT0158500 | LINC00707 | Transcriptional regulation | _ | Pathogenic process | Lung cancer (LC) | Neoplasms; Respiratory Tract Diseases |
HSALNT0185476 | LINC02470 | _ | _ | Pathogenic process | Non-small cell lung cancer (NSCLC) and overian cancer | Neoplasm |
HSALNT0068302 | LINC02600 | _ | _ | Pathogenic process | Non-small cell lung cancer (NSCLC) and overian cancer | Neoplasm |
HSALNT0123915 | LINC02604 | CeRNA | _ | Pathogenic process | Glioblastoma | Neoplasms |
HSALNT0160932 | MACORIS | Transcriptional regulation | _ | _ | Cardiometabolic Diseases | Cardiovascular Diseases |
HSALNT0171022 | KRTAP5-AS1 | CeRNA | _ | Pathogenic process | Gastric Cancer | Neoplasms; Digestive System Diseases |
HSALNT0215076 | GSC-DT | _ | _ | Developmental process | _ | _ |
HSALNT0072605 | CHAER1 | Translational control | _ | Pathogenic process | Cardiac hypertrophy | Cardiovascular Diseases |
HSALNT0027291 | ODC1-DT | CeRNA | _ | Pathogenic process | Head and neck carcinoma | Neoplasm |
HSALNT0039409 | MAP3K2-DT | _ | _ | Pathogenic process | Polycystic ovary syndrome (PCOS) | Female Urogenital Diseases and Pregnancy Complications |
HSALNT0208284 | ZFHX2-AS1 | Transcriptional regulation | _ | Developmental process | _ | _ |
HSALNT0152349 | LINC02603 | _ | _ | _ | _ | _ |
HSALNT0081596 | TENM3-AS1 | _ | _ | _ | _ | _ |
HSALNT0165522 | LINC00858 | _ | _ | _ | non-small cell lung cancer | Respiratory Tract Diseases |
HSALNT0281930 | SCAT1 | _ | _ | _ | esophagal cancer | Digestive system Diseases |
HSALNT0191750 | LNCOG | _ | _ | _ | osteogenic differenciation | Musculoskeletal Diseases |
HSALNT0246388 | DCXR-DT | _ | _ | _ | prostate cancer | Male Urogenital Diseases |
HSALNT0209659 | NKX2-1-AS1 | _ | _ | _ | lung cancer | Respiratory Tract Diseases |
HSALNT0038250 | ACTR3-AS1 | _ | _ | _ | glioblastoma | Nervous system diseases |
HSALNT0043145 | ITGA6-AS1 | _ | _ | _ | glioblastoma | Nervous system diseases |
HSALNT0281822 | LINC02601 | _ | _ | _ | glioblastoma | Nervous system diseases |
_ | ZKSCAN7-AS1 | _ | _ | _ | glioblastoma | Nervous system diseases |
HSALNT0120721 | GARS-DT | _ | _ | _ | heroine addiction | Nervous system diseases |
HSALNT0093136 | LINCADL | _ | _ | _ | obesity | Digestive system Diseases |
_ | GPRACR | _ | _ | _ | liver cancer | Digestive system Diseases |
HSALNT0082561 | LINC01060 | _ | _ | _ | pancreatic cancer | Digestive system Diseases |
HSALNT0058704 | TBILA | _ | _ | _ | non-small cell lung cancer | Respiratory Tract Diseases |
_ | UGDH-AS1 | _ | _ | _ | invertebral disc degeneration | Musculoskeletal Diseases |
HSALNT0245777 | TNRC6C-AS1 | _ | _ | _ | Thyroid cancer | Endocrine system Disease |
HSALNT0225753 | LINC02244 | _ | _ | _ | obesity | Digestive system Diseases |
_ | NKAIN3-IT1 | _ | _ | _ | glioblastoma | Nervous system diseases |
HSALNT0013113 | NGF-AS1 | _ | _ | _ | dysmenorhea | Female Urogenital Diseases |
HSALNT0031057 | LINC01121 | _ | _ | _ | pancreatic cancer | Digestive system Diseases |
HSALNT0234176 | ARLNC1 | _ | _ | _ | prostate cancer | Male Urogenital Diseases |
_ | MPPED2-AS1 | _ | _ | _ | thyroid neoplasias | Endocrine system Disease |
_ | ZKSCAN2-DT | _ | _ | _ | Hepatocellular carcinoma | Digestive system Diseases |
_ | LINC01703 | _ | _ | _ | Hepatocellular carcinoma | Digestive system Diseases |
HSALNT0144162 | HPYR1 | _ | _ | pathogenic process | H. pylori infection | _ |
HSALNT0172266 | LINC00958 | protein localization,transcriptional regulation | _ | pathogenic process | bladder cancer, glioma | _ |
HSALNT0167574 | SH3PXD2A-AS1 | transcriptional regulation | _ | pathogenic process | colorectal cancer | _ |
_ | SSTR5-AS1 | transcriptional regulation | _ | pathogenic process | neuroendocrine prostate cancer | _ |
_ | TSPOAP1-AS1 | _ | _ | pathogenic process | breast cancer | _ |
_ | LINC00174 | ceRNA | _ | pathogenic process | colorectal carcinoma | _ |
HSALNT0169064 | LINC01561 | ceRNA | _ | pathogenic process | breast cancer | _ |
_ | LINC00514 | transcriptional regulation | _ | pathogenic process | neuroendocrine prostate cancer | _ |
HSALNT0282164 | LINC02595 | _ | _ | pathogenic process | colorectal cancer | _ |
HSALNT0197396 | FZD10-AS1 | _ | _ | _ | _ | _ |
_ | LINC01567 | transcriptional regulation | _ | pathogenic process | colon cancer | _ |
_ | ADPGK-AS1 | transcriptional regulation | _ | pathogenic process | pancreatic cancer | _ |
HSALNT0255381 | RAB11B-AS1 | transcriptional regulation | _ | pathogenic process | osteosarcoma | _ |
HSALNT0237805 | SNHG29 | transcriptional regulation | _ | pathogenic process | acute myeloid leukemia, rheumatoid arthritis | _ |
_ | SNHG17 | transcriptional regulation | _ | pathogenic process | colorectal cancer | _ |
HSALNT0215138 | DICER1-AS1 | transcriptional regulation | _ | pathogenic process | osteosarcoma | _ |
HSALNT0043929 | TTN-AS1 | transcriptional regulation | _ | pathogenic process | esophageal squamous cell carcinoma | _ |
HSALNT0152594 | LINC00092 | transcriptional regulation | _ | pathogenic process | ovarian cancer | _ |
HSALNT0050704 | THUMPD3-AS1 | transcriptional regulation | _ | pathogenic process | Neuron death in stroke | _ |
HSALNT0205980 | LINC00554 | transcriptional regulation | _ | pathogenic process | liver cancer | _ |
HSALNT0141703 | ZFPM2-AS1 | transcriptional regulation | _ | pathogenic process | multiple cancers, gastric carcinogenesis | _ |
_ | HOXB-AS1 | transcriptional regulation | _ | pathogenic process | autosomal dominant polycistic kidney disease | _ |
HSALNT0167650 | CFAP58-DT | transcriptional regulation | _ | pathogenic process | innate immune response to viral infection | _ |
_ | FAM230A | _ | _ | _ | _ | _ |
_ | CPNE8-AS1 | transcriptional regulation | _ | pathogenic process | cervical cancer | _ |
_ | THORLNC | transcriptional regulation | _ | pathogenic process | melanoma, skin squamous cell carcinoma,osteosarcoma, renal cell carcinoma | _ |
_ | IATPR | transcriptional regulation | _ | pathogenic process | breast cancer, gallbladder cancer | _ |
HSALNT0242280 | PICART1 | transcriptional regulation | _ | pathogenic process | breast cancer, colorectal cancer, lung cancer | _ |
_ | LINC02599 | transcriptional regulation | _ | pathogenic process | breast cancer | _ |
HSALNT0183231 | ETS1-AS1 | transcriptional regulation | _ | pathogenic process | gastric cancer, neuroblastoma | _ |
_ | MAPK6-DT | transcriptional regulation | _ | pathogenic process | liver cancer | _ |
HSALNT0036655 | IL1R1-AS1 | transcriptional regulation | _ | pathogenic process | Oral squamous cell carcinoma, breast cancer | _ |
HSALNT0001134 | LINC01672 | transcriptional regulation | _ | pathogenic process | Esophageal squamous cell carcinoma | _ |
HSALNT0135857 | SIRLNT | ceRNA | _ | pathogenic process | Breast cancer | _ |
HSALNT0135484 | LINC01605 | transcriptional regulation | _ | pathogenic process | Colon Cancer, Bladder cancer | _ |
HSALNT0184552 | GAU1 | transcriptional regulation | _ | pathogenic process | Neuroblastoma and retinoblastoma | _ |
HSALNT0287294 | LINC00894 | transcriptional regulation | _ | pathogenic process | Lung adenocarcinoma | _ |
HSALNT0000250 | LINC02593 | _ | _ | pathogenic process | breast cancer, hepatocellular carcinoma | _ |
HSALNT0241060 | LINC02594 | _ | _ | _ | gastric cancer | _ |
HSALNT0022481 | LINC01705 | transcriptional regulation | _ | pathogenic process | gastric cancer | _ |
HSALNT0022477 | LINC02474 | transcriptional regulation | _ | pathogenic process | gastric cancer | _ |
HSALNT0030809 | LINC02590 | transcriptional regulation | _ | pathogenic process | gastric cancer | _ |
HSALNT0170966 | MUC5B-AS1 | transcriptional regulation | _ | pathogenic process | lung adenocarcinoma | _ |
HSALNT0275151 | FAM230D | _ | _ | _ | _ | _ |
HSALNT0275163 | FAM230E | _ | _ | _ | _ | _ |
HSALNT0275179 | FAM230F | _ | _ | _ | _ | _ |
_ | FAM230G | _ | _ | _ | _ | _ |
_ | FAM230H | _ | _ | _ | Papillary thyroid carcinoma | _ |
_ | FAM230I | _ | _ | _ | _ | _ |
HSALNT0275150 | FAM230J | _ | _ | _ | _ | _ |
HSALNT0103387 | HCG14 | transcriptional regulation | _ | pathogenic process | Celiac disease, Nutritional and Metabolic Diseases | _ |
HSALNT0001419 | LNCTAM34A | ceRNA | _ | developmental process | Colon Cancer | _ |
_ | LINC01510 | transcriptional regulation, ceRNA | _ | pathogenic process | Colorectal cancer, Non-small cell lung cancer | _ |
_ | LNCOC1 | transcriptional regulation | _ | pathogenic process | Ovarian cancer | _ |
_ | LGALSL-DT | transcriptional regulation | _ | pathogenic process | Postmenopausal osteoporosis (PMOP) | _ |
HSALNT0002862 | LINC02596 | transcriptional regulation | _ | pathogenic process | Postmenopausal osteoporosis (PMOP) | _ |
_ | DEC1 | _ | _ | _ | _ | _ |
_ | RN7SK | _ | _ | _ | _ | _ |
_ | RN7SL1 | _ | _ | _ | _ | _ |
_ | MYOPARR | _ | _ | _ | _ | _ |
_ | PCED1B-AS1 | _ | _ | _ | _ | _ |
_ | UMLILO | _ | _ | _ | _ | _ |
_ | LINC02631 | _ | _ | _ | _ | _ |
_ | BMNCR | _ | _ | _ | _ | _ |
_ | ZEBTR | _ | _ | _ | _ | _ |
_ | SNHG31 | _ | _ | _ | _ | _ |
_ | ILF3-DT | _ | _ | _ | _ | _ |
_ | LINC00574 | _ | _ | _ | _ | _ |
_ | CEBPA-DT | _ | _ | _ | _ | _ |
_ | BABAM2-AS1 | _ | _ | _ | _ | _ |
_ | [[]] | _ | _ | _ | _ | _ |
_ | SNHG30 | _ | _ | _ | _ | _ |
_ | RCC2-AS1 | _ | _ | _ | _ | _ |
_ | NIPBL-DT | _ | _ | _ | _ | _ |
_ | PRDM16-DT | _ | _ | _ | _ | _ |
_ | BCL6-AS1 | _ | _ | _ | _ | _ |
_ | C1orf220 | _ | _ | _ | _ | _ |
_ | MIR122HG | _ | _ | _ | _ | _ |
_ | RB1-DT | _ | _ | _ | _ | _ |
_ | PANTR1 | _ | _ | _ | _ | _ |
_ | C11orf72 | _ | _ | _ | _ | _ |
_ | CT66 | _ | _ | _ | _ | _ |
_ | CAPN10-DT | _ | _ | _ | _ | _ |
_ | MIR1915HG | _ | _ | _ | _ | _ |
_ | CT75 | _ | _ | _ | _ | _ |
_ | [[]] | _ | _ | _ | _ | _ |
_ | MIR9-3HG | _ | _ | _ | _ | _ |
_ | RN7SL2 | _ | _ | _ | _ | _ |
_ | RN7SL3 | _ | _ | _ | _ | _ |
_ | CT70 | _ | _ | _ | _ | _ |
_ | CT69 | _ | _ | _ | _ | _ |
_ | FLVCR1-DT | _ | _ | _ | _ | _ |
_ | C10orf91 | _ | _ | _ | _ | _ |
_ | CEP83-DT | _ | _ | _ | _ | _ |
_ | CSTF3-DT | _ | _ | _ | _ | _ |
_ | CTBP1-DT | _ | _ | _ | _ | _ |
_ | FAM201B | _ | _ | _ | _ | _ |
_ | MAFG-DT | _ | _ | _ | _ | _ |
_ | RPP38-DT | _ | _ | _ | _ | _ |
_ | CDRT3 | _ | _ | _ | _ | _ |
_ | DLEU2L | _ | _ | _ | _ | _ |